Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 449 of 6351
-
Chilling the brain during stroke: could cold saline boost recovery?
Disease control Not yet recruitingA multicenter, prospective, open-label, blinded-endpoint, randomized controlled trial to assess the effectiveness and safety of catheter-based focal intracranial hypothermia combined with endovascular reperfusion therapy for acute patients with a Large Core Infarction.
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New injection after liver ablation aims to stop colorectal cancer in its tracks
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a new injectable drug (IP-001), administered after standard liver tumor ablation, can help prevent cancer from returning in people (males/females, ≥18 years old) with colorectal cancer that has spread only to the liver. The study wil…
Phase 2/3 • Sponsor: Immunophotonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New artificial cornea implant offers hope for patients with failed transplants
Disease control Not yet recruitingThe EndoArt® device is intended to treat patients with chronic corneal edema due to endothelial dysfunction, in whom prior multiple keratoplasty (EK/PK) have failed, and who are not reasonable candidates for any form of corneal transplant, including penetrating keratoplasty. The…
Sponsor: Eye-yon Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New liver dialysis machine could save lives in severe liver failure
Disease control Not yet recruitingThis study is intended to demonstrate the efficacy and safety of the DIALIVE Liver Dialysis Device when incorporated into the standard management plan for participants with A-TANGO ACLF grade 2-4. A total of 72 evaluable participants, aged 18-70, will be enrolled in up to 12 cli…
Phase 3 • Sponsor: Yaqrit Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Psychedelic therapy gets personal: music or mindfulness for depression?
Symptom relief Not yet recruitingThe goal of this pilot clinical trial is to learn whether it is feasible to individually tailor psilocybin-assisted psychotherapy (PAP) for people with treatment-resistant depression (TRD) based on their personal preferences. The study also aims to explore whether two different p…
Phase 2 • Sponsor: Kyle Greenway • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis is an prospective, open label, multicenter study to evaluate the efficacy and safety of neoadjuvant Iparomlimab and Tuvonralimab (QL1706) in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Immunotherapy plus chemo aims to extend lives in tough lung cancer
Disease control Not yet recruitingThis is a multicenter phase II study enrolling treatment- naïve patients with metastatic or recurrent squamous carcinoma of the lung
Phase 2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New DNA test could speed up brain infection diagnosis
Diagnosis Recruiting nowDelve Bio, Inc. is a developer of novel mNGS tests with the goal of aiding in the diagnosis of infectious diseases in several clinical indications that may not have alternative traditional diagnostic methods routinely available. A proof of concept for the clinical utility of this…
Sponsor: Delve Bio, Inc. • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New gene therapy hopes to fix fatal brain diseases
Disease control Not yet recruitingThe project aims to optimize and validate this new therapeutic strategy using cells from GM2 patients to evaluate the cross-correction of neurons in vitro by the culture medium of genetically modified myeloid cell lines. The ultimate goal is to demonstrate the potential of CHS-TG…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Can a simple drug prevent dangerous bleeding in C-Sections?
Prevention Not yet recruitingInvestigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.
Phase 3 • Sponsor: Sultan Qaboos University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Triple attack on prostate cancer: drug, surgery, and radiation aim to stop spread
Disease control Not yet recruitingProstate cancer represents the second most common malignancy in men worldwide. Oligometastatic prostate cancer (OMPC), defined as a transitional state between localized and widespread metastatic disease (≤10 metastatic lesions without visceral metastases), exhibits relatively ind…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on recurrent brain tumors
Disease control Not yet recruitingThis clinical study is designed to evaluate the safety and efficacy of IL13Rα2 CAR-T cells secreting anti-PD-L1 antibody in patients with recurrent malignant glioma. This trial is a multicenter, open-label, non-randomized, single-arm investigator-initiated trial (IIT). Patients w…
Phase 1 • Sponsor: Ming Yang • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Triple-Drug cocktail takes aim at rare, aggressive cancers
Disease control Not yet recruitingTo explore the Objective Response Rate (ORR) of Benmelstobart combined with Anlotinib and chemotherapy as first-line treatment for large-cell neuroendocrine carcinoma of the lung (LCNEC) and extrapulmonary neuroendocrine carcinoma (EP-NEC)
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New heart valve offers hope for patients with severe leaky heart
Disease control Not yet recruitingThe goal of this clinical trial is to assess if the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTO G2 TVSTR) is safe and efficient in treating severe tricuspid regurgitation in adult patients. The main questions it aims to answer are: * Does the tr…
Sponsor: Medira GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Liver cancer hope: triple therapy shows promise in early trial
Disease control Not yet recruitingThis is a prospective, single-arm, phase II clinical study designed to evaluate the efficacy and safety of low-dose bevacizumab plus atezolizumab combined with transarterial chemoembolization followed by hepatic arterial infusion chemotherapy (TACE-HAIC) as first-line treatment f…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New baby vaccine could fight pneumonia
Vaccine Not yet recruitingA Phase III clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13)developed by Sinovac Life Science Co., Ltd will be conducted in infants aged approximately 2 months (42 to 89 days). The objective of the study is to evaluate the immunogenicity and safety of Sinovac P…
Phase 3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 12:35 UTC
-
Nanoparticle steroid spray could transform recovery after sinus surgery
Disease control Recruiting nowThis randomised, single-masked, parallel-group clinical trial will evaluate the efficacy and safety of a topical triamcinolone acetonide-loaded polymeric nanocapsule formulation for postoperative care following endoscopic nasal surgery. Participants will receive either the inves…
Phase 2 • Sponsor: Deraya University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Repositioning arms during lung surgery may cut Post-Op shoulder pain
Symptom relief Recruiting nowThis study is a prospective randomized controlled trial aiming to reduce shoulder pain after lung surgery. Shoulder pain on the surgical side is common after video-assisted thoracoscopic lobectomy, affecting about 20%-58% of patients. It can limit coughing, moving, and sleeping, …
Sponsor: Chengdu Jinjiang Maternity and Child Health Hospital • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a blood thinner boost vision after retinal detachment surgery?
Disease control OngoingThis interventional prospective study was conducted in the Department of Ophthalmology at Lahore General Hospital, Lahore. The study included 60 male and female patients aged 18-65 years who had rhegmatogenous retinal detachment associated with grade C proliferative vitreoretinop…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a cell injection calm the gut after a stem cell transplant?
Disease control By invitation onlyThis study focuses on patients with gastrointestinal-dominant acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. AmiMetosai Injection combined with corticosteroids is administered as first-line treatment. The objective is to evaluate…
Early phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC